Cancer Network Editors

In this slide show we highlight some of the top news on sarcoma in 2016, including the first frontline FDA approval in 40 years, and studies on imaging in Ewing sarcoma, maintenance chemotherapy in osteosarcoma, and more.

This slide show highlights 2016 FDA approvals of cancer treatments, which to date include therapies for RCC, neuroendocrine tumors, Hodgkin lymphoma, CLL, sarcoma, bladder cancer, lung cancer, and breast cancer.

In this slide show we highlight some of the top news on lung cancer in 2016, including an immunotherapy approval from the FDA, and studies on depression in lung cancer patients, serious side effects to watch for when using immunotherapies, and more.

This slide show highlights some of the top news of 2016 on hematologic malignancies, including FDA approvals for myeloma, lymphoma, and leukemia, and studies on transplantation, risk of recurrence in AML patients, and more.

This slideshow takes a look at some of the top kidney cancer news of 2016, including FDA approvals, survival disparities, surgical approaches, and more.

This slide show highlights some of the top prostate cancer news of 2016, including studies on aspirin use and cancer risk, the increased incidence of colorectal tumors in prostate cancer patients, hormone therapy and a link to depression, and more.

This slide show highlights some of the top breast cancer news of 2016, including a study looking at optimal margins in DCIS, a trial on biosimilars, a new FDA approval, and more.

Do you know the ASCO guidelines for metastatic castration-resistant prostate cancer? How about prostate cancer incidence in various countries? Test your knowledge on these topics and more in our latest quiz.

Are you up to date on the latest FDA approvals in advanced breast cancer? How about the latest findings presented at this year’s ESMO Congress?

Do you know what factors increase the risk of melanoma? How about the ins and outs of T staging? Test your knowledge on these topics and more in our latest quiz.

Are you up to date on the different myelodysplastic syndromes as defined by the World Health Organization? How about the rate at which some myelodysplastic syndromes turn into leukemia?

Are you up to date on the latest incidence and mortality numbers in melanoma? How about radiotherapy and drug interactions? Test your knowledge in our latest quiz.

Are you up to date on the known risk factors for multiple myeloma? How about the latest findings presented at this year’s ASCO meeting?

We present a summer reading list of 15 must-reads that cover the history of genes and cancer, the link between so-called junk DNA and disease, uncertainty in medicine, and more.

Read compelling analyses of 5-year trends and projected changes in the oncology clinical drug pipeline, selected from the IMS Institute for Healthcare Informatics’ recent “Global Oncology Trend Report.”

Do you know the yearly incidence of each type of leukemia? How about the rate of leukemia in children and adolescents?

Are you up to date on the latest BRAF and MEK inhibitors used in melanoma? How about the most common location of metastasis in uveal melanoma? Answer these questions and more.

Can you name all of the approved melanoma agents that modulate the immune system? How about the targets and side effects associated with these treatments? Answer these questions and more.

Do you know which tests are essential in the workup of newly diagnosed patients with Hodgkin lymphoma? How about the appropriate duration of radiation treatment in these patients? Answer these questions and more.

Do you know incidence of breast cancer in the United States? How about the proportion of breast cancer patients who are men?

Do you know incidence of lung cancer in the United States? How about which lymph node station is not evaluable with esophageal ultrasound-guided biopsy in newly diagnosed disease? Answer these questions and more.

Do you know the prevalence of triple-negative breast cancer? How about the patient makeup in the START A and START B trials, which tested hypofractionated radiotherapy for breast cancer? Answer these questions and more.

This slide show highlights some of the top stories of the month, including the approval of a new agent for RCC, a study that found declines in prostate cancer deaths have mirrored the declines in smoking rates, and more.

Do you know the least common site for lung cancer metastasis? How about the best test for determining distant spread of disease? Answer these questions and more.

In this March 2016 news roundup we highlight two new FDA indications, chemotherapy’s long-term effect on fertility, the link between BMI and thyroid cancer, and more.

Do you know what percentage of lung cancer patients present with intracranial metastases? Or the most common renal abnormality seen in the presence of lung cancer? Answer these questions and more.

Do you know the most common site of metastasis in soft-tissue sarcoma? Or which histologies are most sensitive to chemotherapy? Answer these questions and more.

In this news roundup we highlight new FDA indications, the overuse of advanced imaging in breast cancer, MAPK inhibition in melanoma, and more.

This slide show includes some of the top highlights from the 2016 ASCO Cancer Survivorship Symposium, including studies on whether lymphoma survivors receive the recommended care, how personalization improved survivorship care plan adherence among breast cancer patients, and more.

This slide show includes highlights from the 2016 ASCO Gastrointestinal Cancers Symposium, including studies on pancreatic cancer patients treated at a high-volume center, Lutathera in patients with midgut neuroendocrine tumors, and more.